Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12


Hafnium oxide nanoparticles: toward an in vitro predictive biological effect?

Marill J, Anesary NM, Zhang P, Vivet S, Borghi E, Levy L, Pottier A.

Radiat Oncol. 2014 Jun 30;9:150. doi: 10.1186/1748-717X-9-150.


The combination of the antiviral agent cidofovir and anti-EGFR antibody cetuximab exerts an antiproliferative effect on HPV-positive cervical cancer cell lines' in-vitro and in-vivo xenografts.

Deberne M, Levy A, Mondini M, Dessen P, Vivet S, Supiramaniam A, Vozenin MC, Deutsch E.

Anticancer Drugs. 2013 Jul;24(6):599-608. doi: 10.1097/CAD.0b013e3283612a71.


Multipolar mitosis of tetraploid cells: inhibition by p53 and dependency on Mos.

Vitale I, Senovilla L, Jemaà M, Michaud M, Galluzzi L, Kepp O, Nanty L, Criollo A, Rello-Varona S, Manic G, Métivier D, Vivet S, Tajeddine N, Joza N, Valent A, Castedo M, Kroemer G.

EMBO J. 2010 Apr 7;29(7):1272-84. doi: 10.1038/emboj.2010.11. Epub 2010 Feb 25.


p53 represses the polyploidization of primary mammary epithelial cells by activating apoptosis.

Senovilla L, Vitale I, Galluzzi L, Vivet S, Joza N, Younes AB, Rello-Varona S, Castedo M, Kroemer G.

Cell Cycle. 2009 May 1;8(9):1380-5. Epub 2009 May 26.


Chk1 inhibition activates p53 through p38 MAPK in tetraploid cancer cells.

Vitale I, Senovilla L, Galluzzi L, Criollo A, Vivet S, Castedo M, Kroemer G.

Cell Cycle. 2008 Jul 1;7(13):1956-61.


Improved cellular pharmacokinetics and pharmacodynamics underlie the wide anticancer activity of sagopilone.

Hoffmann J, Vitale I, Buchmann B, Galluzzi L, Schwede W, Senovilla L, Skuballa W, Vivet S, Lichtner RB, Vicencio JM, Panaretakis T, Siemeister G, Lage H, Nanty L, Hammer S, Mittelstaedt K, Winsel S, Eschenbrenner J, Castedo M, Demarche C, Klar U, Kroemer G.

Cancer Res. 2008 Jul 1;68(13):5301-8. doi: 10.1158/0008-5472.CAN-08-0237.


Inhibition of Chk1 kills tetraploid tumor cells through a p53-dependent pathway.

Vitale I, Galluzzi L, Vivet S, Nanty L, Dessen P, Senovilla L, Olaussen KA, Lazar V, Prudhomme M, Golsteyn RM, Castedo M, Kroemer G.

PLoS One. 2007 Dec 26;2(12):e1337.


Selective resistance of tetraploid cancer cells against DNA damage-induced apoptosis.

Castedo M, Coquelle A, Vitale I, Vivet S, Mouhamad S, Viaud S, Zitvogel L, Kroemer G.

Ann N Y Acad Sci. 2006 Dec;1090:35-49.


Enrichment of non-synchronized cells in the G1, S and G2 phases of the cell cycle for the study of apoptosis.

Coquelle A, Mouhamad S, Pequignot MO, Braun T, Carvalho G, Vivet S, Métivier D, Castedo M, Kroemer G.

Biochem Pharmacol. 2006 Nov 30;72(11):1396-404. Epub 2006 Apr 29.


Apoptosis regulation in tetraploid cancer cells.

Castedo M, Coquelle A, Vivet S, Vitale I, Kauffmann A, Dessen P, Pequignot MO, Casares N, Valent A, Mouhamad S, Schmitt E, Modjtahedi N, Vainchenker W, Zitvogel L, Lazar V, Garrido C, Kroemer G.

EMBO J. 2006 Jun 7;25(11):2584-95. Epub 2006 May 4.


Cell cycle-dependent cytotoxic and cytostatic effects of bortezomib on colon carcinoma cells.

Coquelle A, Mouhamad S, Pequignot MO, Braun T, Carvalho G, Vivet S, Métivier D, Castedo M, Kroemer G.

Cell Death Differ. 2006 May;13(5):873-5. No abstract available.


Preapoptotic chromatin condensation upstream of the mitochondrial checkpoint.

Andreau K, Castedo M, Perfettini JL, Roumier T, Pichart E, Souquere S, Vivet S, Larochette N, Kroemer G.

J Biol Chem. 2004 Dec 31;279(53):55937-45. Epub 2004 Oct 21.

Supplemental Content

Support Center